Flare-up phenomenon or pseudoprogression after CAR T-cell infusion in non-Hodgkin aggressive lymphomas
Leuk Lymphoma
.
2023 Mar;64(3):707-711.
doi: 10.1080/10428194.2022.2161304.
Epub 2022 Dec 27.
Authors
Clara Sortais
1
,
Stéphanie Cordeil
2
,
Estelle Bourbon
2
,
Maryam Idlhaj
2
,
Emmanuelle Ferrant
2
,
Violaine Safar
2
,
Camille Golfier
2
,
Anne Lazareth
2
,
Fadhela Bouafia-Sauvy
2
,
Jérémie Tordo
3
,
Hervé Ghesquières
2
4
,
Pierre Sesques
2
,
Emmanuel Bachy
2
4
Affiliations
1
Department of Hematology, CHU de Nantes, Nantes, France.
2
Department of Hematology, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
3
Department of Nuclear Medicine, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
4
Lymphoma Immuno-biology (LIB) Research Unit, Claude Bernard Lyon 1 University, Lyon, France.
PMID:
36573418
DOI:
10.1080/10428194.2022.2161304
No abstract available
MeSH terms
Antigens, CD19
Humans
Immunotherapy, Adoptive / adverse effects
Lymphoma, Non-Hodgkin* / diagnosis
Lymphoma, Non-Hodgkin* / therapy
T-Lymphocytes
Substances
Antigens, CD19